The utility of genomics and functional imaging to predict sunitinib pharmacokinetics and pharmacodynamics: The predict SU study
Exploratory associations were observed between sunitinib PK/PD with hepatic functional imaging with extensive pharmacogenomics. Further validation is required.
Authors
- M. Burge
- A Matera
- Ian Campbell (ORCID: https://orcid.org/0000-0002-1014-4038)
- E. Link
- Guy C. Toner (ORCID: https://orcid.org/0000-0001-9873-3592)
- Rodney J. Hicks (ORCID: https://orcid.org/0000-0002-0758-0824)
- Simone M. Rowley (ORCID: https://orcid.org/0000-0002-5897-7979)
- Christos S. Karapetis (ORCID: https://orcid.org/0000-0003-1741-996X)
- David Pook (ORCID: https://orcid.org/0000-0002-1744-3022)
- Mick Thompson
- Michael Michael
- Vinod Ganju
Institutions
- The University of Melbourne (AU)
- Royal Brisbane and Women's Hospital (AU)
- Peter MacCallum Cancer Centre (AU)
- Monash Medical Centre (AU)
- Flinders Medical Centre (AU)
- Peninsula Health (AU)
Publication Details
- Journal
- British Journal of Clinical Pharmacology
- Published
- 2026-01-04
- DOI
- https://doi.org/10.1002/bcp.70431
- Primary Topic
- Lung Cancer Treatments and Mutations
- Type
- article
- Field-Weighted Citation Impact
- 0.00